LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.70 / 10
Netural
Technical assessment gives LXEO a neutral 3.7/10 rating. MACD Death Cross and Marubozu White signal bearishness, while Long Lower Shadow offers limited support. Overall, bearish patterns outnumber bullish ones, indicating a fragile price outlook.
Analysis Checks(1/4)
Long Lower Shadow
Score6.37/10
Win Rate52.44%
Hist. Signals82
Avg Return2.51%
Score6.37/10
Win Rate52.44%
Hist. Signals82
Avg Return2.51%
MACD Death Cross
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Long Upper Shadow
Score2.88/10
Win Rate50.00%
Hist. Signals74
Avg Return-0.23%
Score2.88/10
Win Rate50.00%
Hist. Signals74
Avg Return-0.23%
Marubozu White
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.61%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.61%
Long Lower Shadow
Score6.37/10
Win Rate52.44%
Hist. Signals82
Avg Return2.51%
Score6.37/10
Win Rate52.44%
Hist. Signals82
Avg Return2.51%
Long Upper Shadow
Score2.88/10
Win Rate50.00%
Hist. Signals74
Avg Return-0.23%
Score2.88/10
Win Rate50.00%
Hist. Signals74
Avg Return-0.23%
MACD Death Cross
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Marubozu White
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.61%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-3.61%
What is the current technical signals for LXEO?
- LXEO presents a Netural setup with a Technical Score of 3.70/10. Key technical indicators highlight an RSI of 41.66 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 6.65. Traders should monitor key support at 5.50 and resistance at 5.96.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
